Flucloxacillin sodium compacted

Cloxacillin sodium compacted

Centrient Pharmaceuticals provides wide range of semi-synthetic penicillins which includes cloxacillin sodium compacted. Characteristics: granules obtained by means of dry compaction of the crystalline powder without adding any excipients. Application: the product is suitable for the manufacture of capsule...

Cloxacillin sodium powder

Centrient Pharmaceuticals provides wide range of semi-synthetic penicillins which includes cloxacillin sodium powder. Characteristics: a crystalline powder, hygroscopic. Application: the product is suitable for the manufacture of dry syrup formulation. The appropriate excipients should be added. Therapeuti...

Dicloxacillin compacted

Dsm Sinochem Pharmaceuticals provides wide range of semi-synthetic penicillins which includes dicloxacillin compacted. Characteristics: granules obtained by means of dry compaction of the crystalline powder without adding any excipients. Application: the product is suitable for the manufacture of capsules ...

Dsm Sinochem Pharmaceuticals provides wide range of semi-synthetic penicillins which includes flucloxacillin sodium compacted. Characteristics: granules obtained by means of dry compaction of the crystalline powder without adding any excipients. Application: the product is suitable for the manufacture of c...

Flucloxacillin sodium powder

Centrient Pharmaceuticals provides wide range of semi-synthetic penicillins which includes flucloxacillin sodium powder. Characteristics: a crystalline powder, hygroscopic. Application: the product is suitable for the manufacture of dry syrup formulation. The appropriate excipients should be added. Therape...

Nystatin micronized

Centrient Pharmaceuticals provides wide range of anti-fungals which includes nystatin micronized. Characteristics: a microfine crystalline powder. Application: the product is suitable for the manufacture of (extemporaneous) oral suspensions. Therapeutic category: polyene antibiotic with antifungal act...

Nystatin mycelium

Centrient Pharmaceuticals (“Centrient”), the business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals, today announced the completion of the acquisition of Astral SteriTech Private Limited (“Astral SteriTech”).

With the addition of Astral SteriTech’s Semi-Synthetic Cephalosporin and Semi-Synthetic Penicillin sterile injectable finished dosage forms to Centrient’s product portfolio, the company can now further meet the needs of customers and reach more patients with its critical life-saving medicine.

Available Marketing Authorizations